Airway Clearance Devices Market - By Device Type (Flutter Mucus Clearance Device, High Frequency Chest Wall Oscillation (HFCWO)), By Application (Cystic Fibrosis, Bronchiectasis), By End-use (Homecare Settings), & Forecast, 2023 – 2032

Airway Clearance Devices Industry Analysis

Airway Clearance Devices Market size was valued at around USD 579 million in 2022 and is projected to reach over USD 946 million by 2032. The increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disorder (COPD), cystic fibrosis, and bronchiectasis is a significant driver for the market expansion.
 

To get more details on this report: Request Free Sample PDF
 

According to the survey of the United States Medicare, in 2022, around estimated 350,000 to 500,000 individuals in the U.S. suffer from bronchiectasis. This prevalence surges with age with around 8- to 10-fold difference in prevalence among adults aged 60 years & above. Reports from European countries such as the UK and Germany highlights similar differences in prevalence. Also, the rising awareness about these conditions and the need for effective airway clearance therapies have led to an increased demand for these devices.
 

Airway clearance devices are medical devices designed to assist in clearing mucus, secretions, and other materials from the airways of individuals with respiratory conditions such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and asthma. These devices play a crucial role in improving lung function, reducing the risk of respiratory infections, and enhancing overall respiratory health.
 

However, the lack of awareness among the general populace regarding cystic fibrosis & its therapeutic alternatives, particularly airway clearance devices may impede the business development. Many people are unaware that these devices exist as a treatment option for respiratory conditions such as COPD, cystic fibrosis, bronchiectasis, etc. This lack of awareness is owing to the limited use and knowledge, as these devices are relatively new & are not widely adopted in clinical practice. Also, the limited public education campaigns and initiatives specifically targeting cystic fibrosis may result in insufficient knowledge and understanding among the general population.
 

COVID-19 Impact

The emergence of COVID-19 is an unprecedented public health concern that had negatively affected the airway clearance devices market progress. Nation-wide lockdowns, and emergencies were imposed in various countries and maintaining crucial medical resources was given priority owing to COVID-19. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations. These developments enforced delays or suspension in the routine care by several healthcare settings, including respiratory care practice. This limitation has affected patients' ability to receive in-person assessments, training, and support for airway clearance device use.
 

Moreover, the homecare services, including respiratory therapy and support for airway clearance devices was impacted due to the pandemic. Although, the market is set to witness significant growth in the coming years with the surging product adoption & practice volume.
 

Airway Clearance Devices Market Trends

The increasing prevalence of multiple respiratory conditions such as cystic fibrosis, neuromuscular, bronchiectasis, immotile cilia syndrome, etc. is expected to drive the market expansion. This surge in respiratory conditions has created a strong demand for effective management and treatment options, including airway clearance devices. As per the Global Burden of Disease Study, in 2018, respiratory diseases were ranked the third leading cause of death globally, accounting for 10.8% of all deaths. The WHO estimates also state that the COPD, in particular, affects approximately 384 million people worldwide, as of 2021. This increasing prevalence of respiratory conditions is set to drive the adoption of airway clearance devices.
 

As per the Medline Plus statistics, in 2021, cystic fibrosis is a common genetic disease within the U.S. population and occurs in 1 in 2,500 to 3,500 new-borns. There are approximately 40,000 children and adults living with cystic fibrosis in the U.S. and an estimated 105,000 people have been diagnosed with the disease across 94 countries. Thus, the high prevalence of these conditions is set to foster the product adoption.
 

The growing prevalence of respiratory disorders, coupled with increasing awareness, diagnosis rates, and the emphasis on personalized care, has fueled the demand for airway clearance devices. Businesses operating in this sector have an opportunity to meet the needs of a growing patient population by offering innovative, user-friendly, and homecare-compatible airway clearance devices. By addressing the rising demand for respiratory care, businesses in the market can contribute to improved patient outcomes and enhanced quality of life for individuals living with respiratory disorders.  
 

 Airway Clearance Devices Type Segmentation

To get more details on this report: Request Free Sample PDF
 

Based on device type, the airway clearance devices market is segmented as positive expiratory pressure (PEP), flutter mucus clearance device, high frequency chest wall oscillation (HFCWO), intrapulmonary percussive ventilation (IPV), and others. Flutter mucus clearance device segment was valued at more than USD 177 million in 2022. This majority revenue share is primarily attributed to the higher preference and adoption of flutter mucus clearance device. The effectiveness of the Flutter device in facilitating mucus clearance has been supported by clinical evidence and studies. Positive clinical outcomes and patient testimonials drive the adoption of the device by healthcare professionals and patients.
 

Also, this device offers a user-friendly and portable design, making it convenient for patients to use at home or on the go. Its ease of use and patient comfort also contributes to increased adoption and demand for the device, leading to segment growth. Thus, the efficacy, clinical evidence, patient preference, and comfort are some of the key variables that are expected to spur the business statistics.
 

Airway Clearance Devices Application Segmentation

To get more details on this report: Request Free Sample PDF
 

Based on application, the airway clearance devices market is segmented as cystic fibrosis, neuromuscular, bronchiectasis, immotile cilia syndrome, and others. The cystic fibrosis segment is expected to propel at a 4.4% CAGR from 2023-2032. This highest market share is due to the high prevalence & incidence rates associated with this condition. Cystic fibrosis (CF) has traditionally been defined as the most common life-threatening inherited disorder.
 

According to the Cystic Fibrosis Foundation, in 2020, an estimated 70,000 people worldwide are living with cystic fibrosis. Additionally, advancements in medical care and increased life expectancy have contributed to a growing adult cystic fibrosis population. This expansion in the patient pool underscores the need for effective airway clearance devices.
 

Airway Clearance Devices End-use Segmentation

Based on end-use, the airway clearance devices market is segmented as hospitals, homecare settings, ambulatory surgical centers, and others. The homecare settings segment was valued at over USD 340 million in 2022. This is majorly attributed to the surging patient preference for the use of airway clearance devices in homecare settings. The trend towards providing respiratory care in home settings has gained momentum, driven by factors such as patient convenience, cost-effectiveness, and the desire to reduce hospital readmissions.
 

Airway clearance devices that are portable, user-friendly, and suitable for home use have experienced a surge in demand. The ability for patients to self-manage their respiratory conditions with proper training and guidance further contributes to market landscape. Also, the development of easy to use & convenient airway clearance devices is further set to fuel its adoption in the homecare settings.
 

Airway Clearance Devices Regional Analysis

The U.S. airway clearance devices market is predicted to reach over USD 312 million by 2032. This is owing to several variables including the high disease burden of respiratory conditions, rise in awareness regarding airway clearance devices, and supportive legislative policies in the country. For instance, as per the American Lung Association, in 2018, approximately 9 million adults, or 3.6% of individuals aged 18 or above were suffering from chronic bronchitis in the U.S. Similarly, around 2 million adults were suffering from emphysema. Moreover, facilitative healthcare policies and reimbursement frameworks that support the use of airway clearance devices in cystic fibrosis management.
 

Airway Clearance Devices Industry Leaders

Some of the major players operating in the airway clearance devices market Hill-Rom Holdings, Inc., Koninklijke Philips N.V., International Biophysical Corporation, Pari Medical Holding GmbH, Dymedso Inc., Vitalograph Ltd., Med Systems, Inc Vyaire Medical, Inc., Smiths Medical, Inc., and Fisher & Paykel Healthcare Limited among others. These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.
 

Airway Clearance Devices Industry Leaders:

• In December 2022, Electromed announced the U.S. FDA clearance of Smartvest Clear way, Airway clearnce device that is designed for high frequency chest wall oscillation (''HFCWO'') therapy. This helped the company to introduce innovative products, further offering a competitive edge over its competitors.
   
• In October 2022, Movair announces commercial launch of luisa life supporting ventilator with high-flow oxygen therapy, an advanced ventilator intended for use in homes, institutions, hospitals, or portable applications for both invasive and non-invasive ventilation. This product launch helped the company to strengthen its product portfolio across the global market.
   

Airway clearance devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue and units in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Device type, 2018 - 2032 (USD Million & Units)

• Positive Expiratory Pressure (PEP)
• Flutter Mucus Clearance Device
• High Frequency Chest Wall Oscillation (HFCWO)
• Intrapulmonary Percussive Ventilation (IPV)
• Others                                              

By Material Type, 2018 - 2032 (USD Million)

• Cystic Fibrosis
• Neuromuscular
• Bronchiectasis
• Immotile Cilia Syndrome
• Others

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Homecare Settings
• Ambulatory Surgical Centers
• Others  

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Switzerland
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt
  • Turkey